What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.
What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.
复制标题
DOI：
10.1002/pon.5921
复制
发表时间：
2022-06
期刊：
影响因子：
3.6
通讯作者：
van der Lee, Marije L.
中科院分区：
文献类型：
--
作者：
Luigjes-Huizer, Yvonne L.;Tauber, Nina M.;Humphris, Gerry;Kasparian, Nadine A.;Lam, Wendy W. T.;Lebel, Sophie;Simard, Sebastien;Smith, Allan Ben;Zachariae, Robert;Afiyanti, Yati;Bell, Katy J. L.;Custers, Jose A. E.;de Wit, Niek J.;Fisher, Peter L.;Galica, Jacqueline;Garland, Sheila N.;Helsper, Charles W.;Jeppesen, Mette M.;Liu, Jianlin;Mititelu, Roxana;Monninkhof, Evelyn M.;Russell, Lahiru;Savard, Josee;Speckens, Anne E. M.;van Helmondt, Sanne J.;Vatandoust, Sina;Zdenkowski, Nicholas;van der Lee, Marije L.
癌症复发恐惧（FCR）被认为是癌症幸存者中最常见的未满足需求。然而，FCR的患病率和诱发因素仍然没有定论。为了支持有针对性的护理，我们提供了一个全面的概述，癌症幸存者和患者中FCR的患病率和严重程度，使用经过验证的癌症复发恐惧量表（FCRI-SF）的简短形式进行测量。我们还报告了FCR与临床和人口统计学特征之间的相关性。这是一项关于FCR患病率的系统性综述和个体参与者数据（IPD）Meta分析。在综述中，我们纳入了所有使用FCRI‐SF的成人（≥18岁）癌症幸存者和患者研究。检索日期：2020年2月7日。使用Joanna Briggs研究所的关键评估工具评估偏倚风险。87项独特研究请求IPD，并为46项研究提供IPD，其中包括来自13个国家的11，226名参与者。主要分析包括9311名受访者。在FCRI-SF（范围0-36）上，58.8%的受访者得分≥13，45.1%的受访者得分≥16，19.2%的受访者得分≥22。FCR随年龄增长而下降，女性报告的FCR高于男性。FCR在癌症类型和大陆以及自癌症诊断以来的所有时间段都有发现。FCR影响相当多的癌症幸存者和患者。因此，重要的是，医疗保健提供者与患者讨论这个问题，并在需要时提供治疗。需要进一步研究如何最好地预防和治疗FCR，并确定与FCR相关的其他因素。该方案已前瞻性注册（PROSPERO CRD 42020142185）。
Care for fear of cancer recurrence (FCR) is considered the most common unmet need among cancer survivors. Yet the prevalence of FCR and predisposing factors remain inconclusive. To support targeted care, we provide a comprehensive overview of the prevalence and severity of FCR among cancer survivors and patients, as measured using the short form of the validated Fear of Cancer Recurrence Inventory (FCRI‐SF). We also report on associations between FCR and clinical and demographic characteristics. This is a systematic review and individual participant data (IPD) meta‐analysis on the prevalence of FCR. In the review, we included all studies that used the FCRI‐SF with adult (≥18 years) cancer survivors and patients. Date of search: 7 February 2020. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool. IPD were requested from 87 unique studies and provided for 46 studies comprising 11,226 participants from 13 countries. 9311 respondents were included for the main analyses. On the FCRI‐SF (range 0–36), 58.8% of respondents scored ≥13, 45.1% scored ≥16 and 19.2% scored ≥22. FCR decreased with age and women reported more FCR than men. FCR was found across cancer types and continents and for all time periods since cancer diagnosis. FCR affects a considerable number of cancer survivors and patients. It is therefore important that healthcare providers discuss this issue with their patients and provide treatment when needed. Further research is needed to investigate how best to prevent and treat FCR and to identify other factors associated with FCR. The protocol was prospectively registered (PROSPERO CRD42020142185).
登录
查看更多内容
迈向基于证据的恐惧乳腺癌幸存者癌症复发的模型。
DOI：
10.1007/s11764-016-0558-z
发表时间：
2017-02
期刊：
Journal of cancer survivorship : research and practice
影响因子：
--
作者：
Custers JA;Gielissen MF;de Wilt JH;Honkoop A;Smilde TJ;van Spronsen DJ;van der Veld W;van der Graaf WT;Prins JB
通讯作者：
Prins JB
DOI：
10.1007/s00520-015-2808-4
发表时间：
2016-02
期刊：
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
影响因子：
--
作者：
Custers JAE;Gielissen MFM;Janssen SHV;de Wilt JHW;Prins JB
通讯作者：
Prins JB
影响因子：
3.6
作者：
Goetze, Heide;Taubenheim, Sabine;Mehnert-Theuerkauf, Anja
通讯作者：
Mehnert-Theuerkauf, Anja
影响因子：
3.7
作者：
Buffart LM;Kalter J;Chinapaw MJ;Heymans MW;Aaronson NK;Courneya KS;Jacobsen PB;Newton RU;Verdonck-de Leeuw IM;Brug J
通讯作者：
Brug J
影响因子：
3.6
作者：
Fardell, Joanna E.;Jones, Georden;Butow, Phyllis
通讯作者：
Butow, Phyllis